Recent Blog Posts
-
Pacific Northwest Research Institute Publishes Key Advances in Rare and Genetic Disease Research Amid National Funding Uncertainty
Despite a challenging year for research funding, PNRI scientists moved discovery forward with 21 studies in the past year, shedding light on genetic disorders, cancer biology, and hidden patterns in the human genome – breakthroughs that demonstrate the impact of continued investment in biomedical research.
-
Pacific Northwest Research Institute Announces Listing of Building at 720 Broadway in Seattle
PNRI lists its 45,000-sq-ft headquarters at 720 Broadway in Seattle for sale to position the institute for future research sustainability and growth.
-
A Summer of Discovery: PNRI’s 2025 SURI Interns Take the Stage
From cancer in clams to rare disease genomics, PNRI’s 2025 SURI interns spent the summer tackling big questions through hands-on research.
-
Carvalho Lab Shares New Insights Into Rare Diseases, Inversions, and Complex Genomic Rearrangements
New research from PNRI’s Carvalho Lab reveals how complex genomic rearrangements like inversions may help solve rare disease cases that defy standard diagnosis.
-
PNRI Announces Leadership Transition and Welcomes New COO
PNRI welcomes new COO Mark Rieder, PhD, and honors retiring CEO Jack Faris, PhD, marking a new chapter in advancing genetic research.
-
Rare Disease, Real Progress: Season 2 of PNRI’s Podcast Is Here
Listen now to PNRI Science: Rare Disease, Real Progress – our latest podcast series featuring conversations from our 2025 Rare Disease Day Symposium with scientists, advocates, and industry leaders accelerating rare disease research.
Recent Media Coverage
Seattle research institute puts longtime headquarters on the market
Puget Sound Business Journal reports on PNRI’s decision to list our longtime Seattle headquarters for $9.5 million while exploring future space options.
A Summer of Discovery: PNRI’s 2025 SURI Interns Take the Stage
Science in Seattle: PNRI’s 2025 SURI interns take the stage—eight projects, new skills, and big discoveries.
PNRI Announces Leadership Transition and Welcomes New COO
Science in Seattle spotlights PNRI’s leadership transition—celebrating CEO Jack Faris, PhD’s service and welcoming Mark Rieder, PhD as our new COO.
Seattle Times Op-Ed: Federal research funding cuts interrupt vital, lifesaving work
The Seattle Times published an op-ed by PNRI CEO, Jack Faris, PhD, and Interim Chief Scientific Officer & Senior Investigator, Aimée Dudley, PhD, highlighting the real-world consequences of when federal research funding is disrupted—not just for scientists, but for the millions of people waiting for a diagnosis, treatment, or cure.
PNRI Welcomes Six New Trustees to Its Board
Science in Seattle spotlights PNRI’s six new trustees—leaders in science, business, finance, governance, and patient advocacy.
‘Immortal’ creatures may reveal clues to contagious cancers
Dr. Michael Metzger weighs in on recent research into transmissible cancer in hydras, connecting it to his lab’s work on contagious cancers in shellfish. He shares insights on how these findings contribute to understanding cancer’s evolution across species.
Media Requests
Please visit our Media Inquiries page to contact us with your request.